Literature DB >> 19732984

Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT.

Evelyn Van de Werf1, Yolande Lievens, Jan Verstraete, Kris Pauwels, Walter Van den Bogaert.   

Abstract

Time measurements were performed on daily treatment delivery with the aim to quantify the impact of quality assurance (QA) using an electronic portal imaging device (EPID) on RT delivery time and to validate the time burden of intensity modulated radiation therapy (IMRT) as an example of advanced technology. Both increased QA and the delivery of IMRT were found to be significant parameters determining daily treatment time (TT), which in turn translates in increased treatment costs.

Mesh：

Year:  2009        PMID： 19732984     DOI： 10.1016/j.radonc.2009.07.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  13 in total

Review 1.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

Review 2.  The evolution of brachytherapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Brian J Davis; Paul L Nguyen; Timothy N Showalter; Peter J Hoskin; Yasuo Yoshioka; Gerard C Morton; Eric M Horwitz
Journal:  Nat Rev Urol       Date:  2017-06-30       Impact factor: 14.432

3.  A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry : A step to QA with in vivo EPID dosimetry.

Authors:  Christos Moustakis; Fatemeh Ebrahimi Tazehmahalleh; Khaled Elsayad; Francis Fezeu; Sergiu Scobioala
Journal:  Strahlenther Onkol       Date:  2020-01-10       Impact factor: 3.621

4.  Radiotherapy facilities, equipment, and staffing in Poland: 2005-2011.

Authors:  Marian Reinfuss; Edward Byrski; Julian Malicki
Journal:  Rep Pract Oncol Radiother       Date:  2013-03-13

5.  Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial.

Authors:  R Fietkau; W Budach; N Zamboglou; H-J Thiel; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

6.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

Review 7.  Systematic review of hypofractionated radiation therapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Nitin Ohri; Timothy N Showalter; Adam P Dicker; Robert B Den
Journal:  Cancer Treat Rev       Date:  2013-03-01       Impact factor: 12.111

8.  Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario.

Authors:  J H E Yong; T McGowan; R Redmond-Misner; J Beca; P Warde; E Gutierrez; J S Hoch
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

9.  Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.

Authors:  H Vorwerk; K Zink; R Schiller; V Budach; D Böhmer; S Kampfer; W Popp; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

Review 10.  A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.

Authors:  Vladimir Avkshtol; Yanqun Dong; Shelly B Hayes; Mark A Hallman; Robert A Price; Mark L Sobczak; Eric M Horwitz; Nicholas G Zaorsky
Journal:  Res Rep Urol       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.